Biocryst Pharmaceuticals (BCRX) Current Leases (2017 - 2026)
Biocryst Pharmaceuticals' Current Leases was $1.09 million in Q2 2026, down 32.4% from $1.62 million a year earlier and down 11.6% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Current Leases (2017 - 2026) Analysis & Trends
At the end of FY2025, Current Leases at Biocryst Pharmaceuticals came in at $1.31 million, down 28.5% from FY2024.
- Current Leases shows a five-year compound annual growth rate of 2.2% (FY2020 to FY2025).
- In earlier years, Current Leases was $1.84 million in FY2024 (+15.4%), $1.59 million in FY2023 (+86.4%) and $853,000 in FY2022.
- The Q2 2026 figure marks the lowest quarterly Current Leases since Q4 2022.
- Compared with a year earlier, Current Leases has declined for five straight quarters, with an average decline of 13.3% over the last seven quarters.
- The best year-over-year quarter for Current Leases over five years was Q4 2023 (growth of 86.4%); the worst was Q2 2026 (a decline of 32.4%).
- Per Business Quant data, BCRX's Current Leases in the three quarters before Q2 2026 was $1.24 million (Q1 2026), $1.31 million (Q4 2025) and $1.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.84 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Dec 31, 2022 | 853,000.00 |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 981,000.00 |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 1.18 Mn |
| Sep 30, 2020 | 925,000.00 |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | 1.38 Mn |
| Dec 31, 2018 | 47,000.00 |
API Access
Biocryst Pharmaceuticals Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();